HRSHF(HRSHF)
HRSHF
No analyst ratings available
No analyst price targets available for HRSHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $310.34B | $326.30B | $343.98B | $378.19B | $408.43B |
| Low | $295.97B | $312.01B | $328.50B | $361.16B | $390.05B |
| High | $321.03B | $349.52B | $362.31B | $398.34B | $430.19B |
| EBITDA Avg | $35.77B | $37.61B | $39.64B | $43.59B | $47.07B |
| Low | $34.11B | $35.96B | $37.86B | $41.62B | $44.95B |
| High | $37.00B | $40.28B | $41.76B | $45.91B | $49.58B |
| EBIT Avg | $24.37B | $25.63B | $27.01B | $29.70B | $32.07B |
| Low | $23.24B | $24.50B | $25.80B | $28.36B | $30.63B |
| High | $25.21B | $27.45B | $28.45B | $31.28B | $33.78B |
| Net Income Avg | $19.73B | $21.61B | $23.70B | $30.17B | $33.44B |
| Low | $18.58B | $20.35B | $22.32B | $28.41B | $31.48B |
| High | $21.10B | $23.11B | $25.34B | $32.26B | $35.75B |
| EPS Avg | $2.14 | $2.34 | $2.57 | $3.27 | $3.63 |
| Low | $2.01 | $2.21 | $2.42 | $3.08 | $3.41 |
| High | $2.29 | $2.51 | $2.75 | $3.50 | $3.88 |
| Analysts (Rev / EPS) | 20 / 1 | 22 / 1 | 10 / 1 | 15 / 1 | 11 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $76.30B | $75.45B |
| Low | $73.52B | $72.70B |
| High | $79.08B | $78.19B |
| EBITDA Avg | $8.79B | $8.70B |
| Low | $8.47B | $8.38B |
| High | $9.11B | $9.01B |
| EBIT Avg | $5.99B | $5.92B |
| Low | $5.77B | $5.71B |
| High | $6.21B | $6.14B |
| Net Income Avg | $5.39B | $3.53B |
| Low | $5.14B | $3.36B |
| High | $5.65B | $3.70B |
| EPS Avg | $0.58 | $0.38 |
| Low | $0.55 | $0.36 |
| High | $0.61 | $0.40 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |